Drugs Approved for Stomach (Gastric) Cancer
- Capecitabine
- Cyramza (Ramucirumab)
- Docetaxel
- Doxorubicin Hydrochloride
- Enhertu (Fam-Trastuzumab Deruxtecan-nxki)
- 5-FU (Fluorouracil Injection)
- Fam-Trastuzumab Deruxtecan-nxki
- Fluorouracil Injection
- Herceptin (Trastuzumab)
- Keytruda (Pembrolizumab)
- Lonsurf (Trifluridine and Tipiracil Hydrochloride)
- Mitomycin
- Nivolumab
- Nivolumab and Hyaluronidase-nvhy
- Opdivo (Nivolumab)
- Opdivo Qvantig (Nivolumab and Hyaluronidase-nvhy)
- Pembrolizumab
- Ramucirumab
- Taxotere (Docetaxel)
- Tevimbra (Tislelizumab-jsgr)
- Tislelizumab-jsgr
- Trastuzumab
- Trifluridine and Tipiracil Hydrochloride
- Vyloy (Zolbetuximab-clzb)
- Xeloda (Capecitabine)
- Zolbetuximab-clzb
Drug Combinations Used in Stomach (Gastric) Cancer
Drugs Approved for Gastroenteropancreatic Neuroendocrine Tumors